Jupiter Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-173,165
Closed -$57.8M 440
2024
Q3
$57.8M Sell
173,165
-705
-0.4% -$268K 0.51% 64
2024
Q2
$71.6M Sell
173,870
-652
-0.4% -$258K 0.68% 32
2024
Q1
$70.5M Sell
174,522
-225
-0.1% -$79.1K 0.67% 34
2023
Q4
$53.6M Buy
174,747
+111,510
+176% +$30.1M 0.53% 46
2023
Q3
$15.3M Buy
+63,237
New +$16.2M 0.17% 163
2022
Q2
Sell
-7,116
Closed -$1.16M 615
2022
Q1
$1.16M Hold
7,116
0.01% 404
2021
Q4
$1.56M Sell
7,116
-3,785
-35% -$793K 0.02% 385
2021
Q3
$2.06M Sell
10,901
-22,090
-67% -$4.03M 0.02% 341
2021
Q2
$5.83M Sell
32,991
-89,477
-73% -$15.4M 0.06% 275
2021
Q1
$20.1M Buy
122,468
+3,031
+3% +$464K 0.2% 139
2020
Q4
$16.6M Buy
119,437
+16,137
+16% +$2.03M 0.17% 158
2020
Q3
$11.5M Buy
+103,300
New +$11.9M 0.12% 191

Other funds holding MEDP

Jupiter Asset Management's MEDP Position: Q4 2024 in Review

Jupiter Asset Management sold out of Medpace (MEDP) in Q4 2024, closing a stake of 173,165 shares — an estimated $57.8M sold.

Jupiter Asset Management first reported a position in MEDP in Q3 2020 and held it in 12 quarters. The position peaked at $71.6M in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Jupiter Asset Management reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 173,165 Medpace shares in Q4 2024, an estimated $57.8M.
  • Jupiter Asset Management first reported a position in Medpace in Q3 2020 and held it in 12 quarters.
  • Jupiter Asset Management's Medpace position peaked at $71.6M in Q2 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Jupiter Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.